Preeclampsia and subsequent risk of cancer in Utah

American Journal of Obstetrics and Gynecology

Volumn 195, Issue 3, 2006, Pages 691-699

  Aagaard Tillery, Kjersti M ^a   Stoddard, Gregory J ^c   Holmgren, Calla ^a   Lacoursiere, D Yvette ^b   Fraser, Alison ^c   Mineau, Geraldine P ^d   Varner, Michael W ^a  

^a Divisions of Maternal Fetal Medicine

^b General Obstetrics and Gynecology   (Singapore)

^c UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Preeclampsia

Indexed keywords

ADULT; ARTICLE; BIRTH; CALCULATION; CANCER EPIDEMIOLOGY; CANCER PREVENTION; CANCER RISK; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; FEMALE; GENDER; HAZARD ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; ONSET AGE; PATIENT INFORMATION; POISSON DISTRIBUTION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROGENY; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; UNITED STATES; UNIVARIATE ANALYSIS;

ADULT; COHORT STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HUMANS; MATERNAL AGE; MULTIVARIATE ANALYSIS; NEOPLASMS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; RETROSPECTIVE STUDIES; RISK; UTAH;

EID: 33748685302     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2006.06.089     Document Type: Article

References (27)

1. National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 183 (2000) S1-S22
2. Levine R.J., and Karumanchi S.A. Circulating angiogenic factors in preeclampsia. Clin Obstet Gynecol 48 (2005) 372-386
3. Roberts J.M., and Cooper D.W. Pathogenesis and genetics of pre-eclampsia. Lancet 357 (2001) 53-56
4. Shou Y., Damsky C.H., and Fisher S.J. Preeclampsia is associated with failure of human cytotophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?. J Clin Invest 99 (1997) 2152-2164
5. Anson-Cartwright L., Dawson K., Holmyard D., Fisher S.J., Lazzarini R.A., and Cross J.C. The gilial cells missing-1 protein is essential for branching morphogenesis in the chorioallantoic placenta. Nat Genet 25 (2000) 311-314
6. Zhou Y., McMaster M., Woo K., Janatpour M., Perry J., Karpanen T., et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and HELLP syndrome. Am J Pathol 160 (2002) 1405-1423
7. Baker P.N., Krasnow J., Roberst J.M., and Yeo K.T. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet Gynecol 86 (1995) 815-821
8. Zhou Y., Fisher S.J., Janatpour M., Genbacev O., Dejana E., Wheelock M., et al. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion?. J Clin Invest 99 (1997) 2139-2151
9. Maynard S.E., Min J.-Y., Merchan J., Lim K.-H., Li J., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111 (2003) 649-658
10. Levine R.J., Thadhani R., Qian C., Lam C., Lim K.-H., et al. Urinary placental growth factor and risk of preeclampsia. JAMA 293 (2005) 77-85
11. Thadani R., Mutter W.P., Wolf M., Levine R.J., Taylor R.N., et al. First trimester placental growth factor and soluble Fms-like tyrosine kinase 1 and risk of preeclampsia. J Clin Endocrin Metab 89 (2004) 770-775
12. Levine R.J., Maynard S.E., Quian C., Lime K.-H., England L.J., et al. Circulating angiogenic factors and the risk of preelampsia. N Engl J Med 350 (2004) 672-683
13. Kendall R.L., and Thomas K.A. Inhibition of vascular endothelial cell growth activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA 90 (1993) 10705-10709
14. Cohn B.A., Cirillo P.M., Christianson R.E., van den Berg B.J., and Sitteri P.K. Placental characteristics and reduced risk of maternal breast cancer. J Natl Cancer Inst 93 (2001) 1133-1140
15. Troisi R., Weiss H.A., Hoover R.N., Potischman N., and Swanson C.A. Pregnancy characteristics and maternal risk of breast cancer. Epidemiology 9 (1998) 641-647
16. Neale R.E., Purdie D.M., Murphy M.F.G., Mineau G.P., Bishop T., and Whiteman D.C. Twinning and the incidence of breast and gynecologic cancers (United States). Cancer Caus Cont 15 (2004) 829-835
17. Kerber R.A., and O'Brien E. A cohort study of cancer risk in relation to family histories of cancer in the Utah Population Database. Cancer 103 (2005) 1906-1915
18. Esplin M.S., Fausett M.B., Fraser A., Kerber R., Mineau G., Carrillo J., et al. Paternal and maternal components of the predisposition to preeclampsia. N Engl J Med 344 (2001) 867-872
19. Bean L., Mineau G., and Anderton D. Fertility change on the American frontier (1990), University of California Press, Berkeley
20. Jorde L.B. Inbreeding in the Utah Mormons: an evaluation of estimates based on pedigrees, isonymy, and migration matrices. Ann Hum Genet 53 (1989) 339-355
21. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Pub Health 79 (1989) 340-349
22. Choudhury J.B. Non-parametric confidence interval estimation for competing risks analysis: application to contraceptive data. Stat Med 21 (2002) 1129-1144
23. Smith G.C.S., Pell J.P., and Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease; a retrospective cohort study of 129,290 births. Lancet 357 (2001) 2002-2006
24. Kestenbaum B., Selinger S.L., Easterling T.R., Gillen D.L., et al. Cardiovascular and thromboembolic events following hypertensive pregnancy. Am J Kidney Dis 42 (2003) 982-989
25. Funai E.F., Friedlander Y., Palteil O., Tiram E., et al. Long term mortality after preeclampsia. Epidemiology 16 (2005) 206-215
26. Rothman K.J., and Greenland S. Modern epidemiology. 2nd ed. (1998), Lippincott-Raven Publishers, Philadelphia
27. Wolf M., Hubel C.A., Lam C., Sampson M., et al. Preeclampsia and further cardiovascular disease: potential role of altered angiogenesis and insulin resistance. J Clin Endocrinol Metab 89 (2004) 6239-6243